WHO WE ARE

Originally set up as part of GSK’s Global Health Programmes, Positive Action was created in 1992 as the first pharmaceutical company community grant-giving programme to support communities affected by HIV and AIDS.

In 2023, Positive Action has continued working towards its goal of ending AIDS by 2030 by providing funding to community-led and community-based organisations around the world through strategic partner collaboration. Embodying ViiV Healthcare’s mission of leaving no person living with and affected by HIV behind, we have expanded our funding for current and new programmes to increase access to HIV testing, prevention, and treatment services for the communities we serve.

OUR WORK

Positive Action provides funding through two funding mechanisms:

KEY RESULTS

THIS REPORT FEATURES PROJECTS FOCUSED ON

Eliminating HIV-related stigma

Eliminating HIV-related stigma:
Zvandiri, Zimbabwe

HIV Prevention

HIV prevention:
Red Somos, Colombia

Harm Reduction

Harm Reduction:
YouthRISE, Nigeria

Paediatrics

Paediatrics:
The Paediatric Breakthrough Partnership, Mozambique, Nigeria and Uganda

WHAT’S NEXT?

As we look to 2024, we are channelling our efforts towards ending paediatric AIDS, reducing HIV-related stigma, increasing awareness and access to harm reduction services for people who use drugs, and implementing HIV prevention strategies. Together with our partners, we will continue to ensure that no one is left behind in our efforts to end the HIV epidemic, by putting people and communities at the forefront of the response.

NP-GBL-HVX-COCO-240017 | June 2024

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the GSK Reporting Tool link https://gsk.public.reportum.com/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you are from outside the UK, you can report adverse events to GSK/ ViiV by selecting your region and market, here.